Francesca Tarantini
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Francesca Tarantini has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Stefano Fumagalli
Department of Experimental and Clinical Medicine, Geriatric Intensive Care Unit, University of Florence, Florence, Italy
3 shared publications - Cees B. de Vos
Department of Cardiology, Laurentius Hospital, Roermond, Netherlands
2 shared publications - Harry J. G. M. Crijns
Department of Cardiology and CARIM, Maastricht University, Cardiovascular Research Institute Maastricht, The Netherlands (H.J.G.M.C.).
2 shared publications Jean-Yves Le Heuzey
Department of Cardiology, Hôpital Européen Georges Pompidou, Paris, France
2 shared publications- Niccolò Marchionni
Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy
2 shared publications - Robby Nieuwlaat
Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada
2 shared publications
Latest Publications
- 1 October 2012
- Published by Springer Nature in Aging Clinical and Experimental Research
- Vol. 24 (5) , 517-523
Characteristics, management and prognosis of elderly patients in the Euro Heart Survey on atrial fibrillation
- 1 October 2012
- Published by Springer Nature in Aging Clinical and Experimental Research
- Vol. 24 (5) , 517-523
Characteristics, management and prognosis of elderly patients in the Euro Heart Survey on atrial fibrillation
- 8 May 2012
- Published by Springer Nature
- Vol. 24 (5) , 517-23
Characteristics, management and prognosis of elderly patients in the Euro Heart Survey on atrial fibrillation.
Atrial fibrillation (AF) is the most frequent sustained arrhythmia of elderly patients, in whom it determines an increase in morbidity and mortality. Aim of this study was to assess age-related differences in the characteristics, management and prognosis of patients with AF in European cardiology practices. The Euro Heart Survey on AF was an observational study sponsored by the European Society of Cardiology. Patients were enrolled between 2003 and 2004 in 182 hospitals of 35 countries. For the purposes of this study, they were categorized into three age-groups: 80 years (n=671). Follow-up was closed in 2005. Compared with general population estimates, patients >80 years were underrepresented in the Euro Heart Survey. The oldest patients were less likely to be enrolled by university or specialized centers, to receive extensive diagnostic testing, and to receive oral anticoagulation despite a worse stroke risk profile. Furthermore, the oldest patients less often received rhythm control therapy, even when presenting with palpitations and non-permanent AF. During 1 year follow-up, elderly patients more often suffered a myocardial infarction, new onset heart failure and major bleedings. They had higher all-cause and cardiovascular mortality. Elderly patients with AF are less often referred to the cardiologist and, based on current guidelines, are inadequately studied and treated, compared to younger counterparts. Education on evidence- based management and the design of randomized controlled trials specifically targeting the elderly, should improve the management and prognosis of this frail segment of the AF population.
- 8 May 2012
- Published by Springer Nature
- Vol. 24 (5) , 517-23
Characteristics, management and prognosis of elderly patients in the Euro Heart Survey on atrial fibrillation.
Atrial fibrillation (AF) is the most frequent sustained arrhythmia of elderly patients, in whom it determines an increase in morbidity and mortality. Aim of this study was to assess age-related differences in the characteristics, management and prognosis of patients with AF in European cardiology practices. The Euro Heart Survey on AF was an observational study sponsored by the European Society of Cardiology. Patients were enrolled between 2003 and 2004 in 182 hospitals of 35 countries. For the purposes of this study, they were categorized into three age-groups: 80 years (n=671). Follow-up was closed in 2005. Compared with general population estimates, patients >80 years were underrepresented in the Euro Heart Survey. The oldest patients were less likely to be enrolled by university or specialized centers, to receive extensive diagnostic testing, and to receive oral anticoagulation despite a worse stroke risk profile. Furthermore, the oldest patients less often received rhythm control therapy, even when presenting with palpitations and non-permanent AF. During 1 year follow-up, elderly patients more often suffered a myocardial infarction, new onset heart failure and major bleedings. They had higher all-cause and cardiovascular mortality. Elderly patients with AF are less often referred to the cardiologist and, based on current guidelines, are inadequately studied and treated, compared to younger counterparts. Education on evidence- based management and the design of randomized controlled trials specifically targeting the elderly, should improve the management and prognosis of this frail segment of the AF population.
- 1 August 2003
- Published by Springer Nature in Aging Clinical and Experimental Research
- Vol. 15 (4) , 310-314
Sex-related differences in the length of disability prior to death in older persons
Background and aims: It is acknowledged that, in spite of their generally worse health, women live longer than men. However, whether women also enjoy longer disability-free lives is still unclear. Using data from a representative, Italian cohort followed for 6 years, this study aimed at estimating differences between men and women in the age of disability onset and in total survival. Methods: In 1989, 651 persons aged ≥65 years were interviewed and their medical status was assessed by a geriatrician. In 1995, the time of onset of disability was reconstructed by re-interviewing 392 survivors and collecting proxy information for 201 subjects who had died. No information was available for 58 subjects who refused to be re-interviewed or were lost to follow-up. Data on changes in functional status were also collected by proxy interview for 34 additional persons who had died during the follow-up period, although they had not been originally interviewed at baseline. Results: Of the 235 deaths, 113 were men and 122 were women. On average, the age at death was 3.5 years higher among women than among men. However, the age at onset of disability was similar in the two sexes. In survival analysis in which age was the time variable, women were as likely as men to develop disability, but significantly less likely to die over the follow-up period. Conclusions: Compared with men, women experience longer disability before death. This may be due to sex-related differences in the lifetime prevalence of lethal vs. disabling diseases.
- 1 August 2003
- Published by Springer Nature in Aging Clinical and Experimental Research
- Vol. 15 (4) , 310-314
Sex-related differences in the length of disability prior to death in older persons
Background and aims: It is acknowledged that, in spite of their generally worse health, women live longer than men. However, whether women also enjoy longer disability-free lives is still unclear. Using data from a representative, Italian cohort followed for 6 years, this study aimed at estimating differences between men and women in the age of disability onset and in total survival. Methods: In 1989, 651 persons aged ≥65 years were interviewed and their medical status was assessed by a geriatrician. In 1995, the time of onset of disability was reconstructed by re-interviewing 392 survivors and collecting proxy information for 201 subjects who had died. No information was available for 58 subjects who refused to be re-interviewed or were lost to follow-up. Data on changes in functional status were also collected by proxy interview for 34 additional persons who had died during the follow-up period, although they had not been originally interviewed at baseline. Results: Of the 235 deaths, 113 were men and 122 were women. On average, the age at death was 3.5 years higher among women than among men. However, the age at onset of disability was similar in the two sexes. In survival analysis in which age was the time variable, women were as likely as men to develop disability, but significantly less likely to die over the follow-up period. Conclusions: Compared with men, women experience longer disability before death. This may be due to sex-related differences in the lifetime prevalence of lethal vs. disabling diseases.